Preprint
Article

This version is not peer-reviewed.

Gas Gangrene in Horses: Retrospective Study of 20 Cases in the Amazon Biome

Submitted:

25 November 2024

Posted:

28 November 2024

You are already at the latest version

Abstract
This is the first study describes, through a retrospective analysis, the epidemiological and clini-copathological findings of gas gangrene in horses in the Amazon biome. The study includes 20animals with muscle and mobility injuries treated at proprieties in the Amazon biome from 2018 to 2024. The affected horses exhibited a sudden onset of severe lameness, swelling, and crepitus in the affected limb. The rapid progression of symptoms, including intense pain, fever, and toxemia, led to the clinical suspicion of gas gangrene. Immediate treatment was crucial, involving ag-gressive surgical debridement to remove necrotic tissue and high doses of broad-spectrum anti-biotics to combat the infection. Despite these efforts, the condition of the horses deteriorated rapidly due to the aggressive nature of the disease and the challenging environment of the Am-azon, which complicates timely veterinary intervention. The age range of the affected horses was from four months to 12 years, with a greater frequency in those over 12 months (80%, 16/20). Necropsy revealed histopathological lesions characterized by intense muscle necrosis, liquefac-tion, and gas formation, suggestive of Clostridium infection. The diagnosis was confirmed by multiplex PCR.
Keywords: 
;  ;  ;  ;  ;  ;  ;  ;  

1. Introduction

Brazil have to the third-largest horse population in the world and the largest in Latin America, with an estimated 5.8 million horses. This sector contributes significantly to the country’s economy, generating approximately 16.5 billion reais and creating around 3.2 million direct and indirect jobs related to horse breeding [1]. However, the equine industry in Brazil faces numerous challenges, particularly regarding poor sanitary management practices. These challenges are often exacerbated by nutritional deficiencies, which create favorable conditions for the occurrence of various infectious diseases within herds, thereby negatively impacting the equine production chain [2,3].
Although clostridial infections are rarely reported in horses, no cases have been documented in the Amazon Biome. However, they pose significant economic and health challenges due to their acute clinical course and the difficulties in diagnosis and treatment [4]. Clostridial infections in horses can lead to severe conditions such as gas gangrene, also known as malignant edema. This condition, a type of clostridial myonecrosis, affects soft tissues and can be caused by several Clostridium species, including Clostridium chauvoei, C. septicum, C. novyi type A, C. perfringens type A, and C. sordellii. Typical entry points for these bacteria include penetrating wounds, open fractures, drug injections, and surgeries performed without proper antisepsis. The mortality rates for gas gangrene in horses are alarmingly high, ranging from 50% to 100% [2,3,5].
The ability of Clostridium species to survive in the environment as resilient spores complicate efforts to control and prevent infections. The lack of commercially available vaccines specific to horses against clostridial infections, with the exception of tetanus, underscores the need for improved preventive measures. Furthermore, the underreporting of clostridiosis in horses, due to the scarcity of detailed publications on the subject, emphasizes the importance of early identification and diagnosis to minimize economic losses and improve animal welfare [6,7].
The Amazon biome, with its unique environmental conditions, presents additional challenges for veterinary care. The region’s vastness, coupled with its climatic and logistical difficulties, often hampers timely veterinary intervention, complicating the management of acute infections such as gas gangrene. This first retrospective study aims to provide a comprehensive analysis of 20 clinical cases of gas gangrene in horses the properties in the Amazon Biome of Pará between 2018 and 2024. By examining the epidemiological, clinical, and pathological findings of these cases, this study seeks to enhance the understanding of gas gangrene in horses within the Amazon biome, thereby contributing to better diagnostic and therapeutic strategies for this severe and often fatal condition, as well as discussion of possible risk factors involved in this Clostridium disease in horses of Amazon Biome

2. Materials and Methods

2.1. Cases

For the purposes of this study, a case of gas gangrene in a horse was defined as a animal presenting with rapid onset of localized or generalized signs of infection, including severe swelling, pain, crepitation of the tissues (indicative of gas formation), and malodorous discharge, accompanied by systemic symptoms such as fever, depression, and inappetence. Diagnosis was confirmed by clinical signs, gross pathology, and bacteriological or molecular detection of Clostridium from infected tissues, consistent with gas gangrene. Cases these study were those with conclusive clinical, pathological, and laboratory findings compatible with gas gangrene caused by Clostridium.
The retrospective study was conducted focusing of the epidemiological data (age, race, sex, place of origin, clinical signs, necropsy findings) on cases of gas gangrene in 20 equines (identified numerically from 1 to 20) that presented between January 2018 and October 2024. Cases were included if they met the following criteria: a).Inclusion Criteria: equines that presented with clinical signs consistent with gas gangrene, including acute onset of swelling, pain, crepitus, and systemic signs of toxemia. A confirmed diagnosis of gas gangrene through microbiological testing that identified Clostridium species via culture, polymerase chain reaction (PCR) and histopathological evidence of myonecrosis with gas formation. b). Exclusion Criteria: Cases were excluded if the diagnosis was not confirmed by molecular or histopathological analysis. This study includes specific details regarding the diagnostic process, epidemiology and risk factor of gangrena and tratament/prevention of this Clostridium disease in horses of Amazon Biome.

2.2. Clinical Evaluation

The clinical examination of all the animals were performed as described by Feitosa [8]. a). Initial examination: each horse underwent a thorough clinical examination following the protocol described by Feitosa [8]. The focus was on identifying symptoms consistent with gas gangrene, such as sudden onset of severe lameness, swelling, crepitus in the affected area, and signs of systemic toxemia. b). Clinical signs documentation: the clinical signs were meticulously documented, including the extent of swelling, the presence of subcutaneous emphysema, pain upon palpation, and the general condition of the horse (fever, tachycardia, tachypnea). c). Microbiological sampling: tissue or fluid samples were aseptically collected from the affected areas for microbiological culture. Microbiological examination for Clostridium species was performed using standard anaerobic culturing techniques. Tissue samples from the affected areas were aseptically collected, homogenized, and inoculated onto selective anaerobic media, such as reinforced clostridial medium and blood agar. The plates were incubated at 37°C in an anaerobic chamber for 48-72 hours. Colonies suspected of being Clostridium species were further characterized through Gram staining, biochemical tests (such as catalase and nitrate reduction), and specific tests for toxin production. In cases where isolates were suspected to be Clostridium, confirmation was performed using multiplex PCR [9]. d). Histopathological analysis: in cases where surgical intervention or necropsy was performed, tissue samples were collected for histopathological examination. These samples were fixed in formalin, processed, and stained with hematoxylin and eosin (H&E) to evaluate the extent of myonecrosis, inflammatory cell infiltration, and the presence of gas vacuoles and bacterial organisms [5].

2.3. Confirmatory Tests: Histopathological Findings and PCR

To further characterize the clinical presentation and pathological impact of gas gangrene in equines, a series of confirmatory tests were conducted on affected horses. These tests included histopathological evaluation and PCR each performed using the following methods: A). Histopathological examination [5]: a.1). Tissue sample collection: tissue samples for histopathological examination were obtained during necropsy or surgical debridement procedures. Samples were collected from the affected musculature, skin, and subcutaneous tissues, with special attention to areas showing gross lesions, such as necrosis and gas formation; a.2). Fixation and processing: the tissue samples were immediately fixed in 10% neutral-buffered formalin for 24-48 hours, followed by routine processing, embedding in paraffin, sectioning at 4-5 microns, and staining with hematoxylin and eosin (H&E) for microscopic examination; a3). Histopathological evaluation: the histopathological evaluation focused on identifying characteristic lesions of gas gangrene, such as extensive myonecrosis, the presence of gas vacuoles, infiltration by neutrophils and macrophages, hemorrhage, and the presence of large, rod-shaped, Gram-positive bacteria. Special stains, such as Gram stain and periodic acid-Schiff (PAS), were also utilized to enhance the identification of bacterial organisms and assess tissue damage. B). PCR [10]: to determine the definitive cause of death, fragments of intact muscle tissue with necrosis of the quadriceps were collected aseptically, frozen, and sent to the Anaerobic Laboratory of the Federal University of Minas Gerais (UFMG) and Biological Institut of São Paulo (IB/SP) for microbiological analysis via multiplex PCR as described by Ribeiro et al. [10]. The multiplex-PCR reactions were performed with 5 ml of DNA added to a mixture containing 1.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl, 200 µM of each dNTP, 3.5 U of Taq Polymerase and the 10 primers: C. septicum Forward AGAATAAACAGAGCTGGAGATG and Reverse CTTCACAAACACAATTCAATAAA; C. chauvoei Forward ATCGGAAACATGAGTGCTGC and Reverse AGTCTTTATGCTTCCGCTAG; C. novyi type A Forward AGAATAAACAGAGCTGGAGATG and Reverse CGCCTACTTGGAAAGTTACTC; C. perfringens type A Forward AATGTTACTGCCGTTGATAG and Reverse CAATCATCCCAACTATGACT; C. sordellii Forward GTAGTGCTTGGACACTCTGA and Reverse ATTGGATCTATTCCAGCTTC. C). Correlation with clinical findings: the histopathological findings were correlated with the clinical presentation, microbiological cultures and PCR results to provide a comprehensive understanding of the pathogenesis and systemic effects of gas gangrene in these cases.

3. Results

Over a study period of six years, a total of 20 horses from five different cities in the state of Pará (Castanhal, Novo Progresso, Santo Antônio do Tauá, São Félix do Xingú, and Soure) were studied. Table 1 provides detailed data on the identification of the 20 animals, including their sex, age, city, PCR results, treatment and outcome. A higher number of cases was observed in males (80%, 16/20) than females (20%, 4/20). Predisposing factors for the occurrence of gas gangrene in equines in these farms in the Amazon Biome observed were the reuse of needles, use of contaminated surgical instruments, and lack of vaccination. Additionally, sharp tree stumps and barbed wire fences in pastures have also been observed to possibly cause skin lacerations, as have spurs used by riders inflicting puncture wounds. These injuries disrupt skin integrity, allowing Clostridium bacteria to penetrate, multiply, and produce toxins, leading to infection. All animals died and necropsies were performed. All the 20 horses with gas gangrene had the confirmatory diagnosis of Clostridium septicum. No statistical analyses were performed, since we did not compare any variables.
Gas gangrene in horses was characterized by a sudden onset of severe clinical signs (Figure 1 and Figure 2) due to the rapid multiplication of Clostridium bacteria and the production of toxins, which lead to extensive tissue necrosis, gas production, systemic toxemia and consequently death of the animal.
Histopathology the all horses revealed severe myonecrosis, characterized by the loss of muscle fiber architecture, with extensive areas of coagulative necrosis. Muscle fibers appear fragmented, with loss of cross-striations, and may be replaced by eosinophilic, amorphous debris.Gas vacuoles may be observed within necrotic muscle fibers, a result of the gas-producing clostridial species. There is typically a mixed inflammatory response, including neutrophils and macrophages, although the infiltration may be limited due to the rapid progression of the disease and the extensive tissue destruction. Histological sections showed thrombosis and damage to blood vessels, contributing to ischemia and further exacerbating the necrosis. Gram-staining of histological sections revealed the presence of large, Gram-positive bacilli, consistent with Clostridium species, within the necrotic tissue. The bacteria are typically found in large clusters or chains. There was diffuse floccular and hyaline muscle necrosis in the skeletal muscle, with many basophil bacilli and marked infiltration of neutrophils, vascular areas with thrombi, diffuse edema and hemorrhage (Figure 3A and 3B), and cytoplasmic vacuolization of hepatocytes in the central lobular region of the liver. Bacillary basophilic and Gram-positive bacterial aggregates were detected by Gram staining of muscle tissues. These lesions were compatible with clostridial myonecrosis, and the microbiological laboratory diagnosis was confirmed by multiplex PCR as the etiological agent of the clinical picture of gas gangrene caused by C. septicum.

4. Discussion

The retrospective study conducted on equine gas gangrene in the Amazon Biome, which involved the analysis of 20 horses almost a decade, offers critical insights into the prevalence, risk factors and impact of C. septicum as the causative agent. Although in horses the disease is most often caused by C. perfringens type A [2,3,6,7,10,14,15,17,18,21,24], sporadic cases associated with other clostridial species have been described, such as C. septicum, but never described in the Amazon Biome and only two case reports in all Brazil [19,27]. All the horses studied died to gas gangrene, underscoring the severe nature of the disease and the rapid progression that leads to high mortality rates. The exclusive identification of C. septicum through PCR in these cases is particularly noteworthy, as it suggests a strong regional association of this pathogen with gas gangrene in horses. This finding raises important considerations for both diagnostic approaches and preventive strategies tailored to the Amazon Biome. Gas gangrene in horses is a severe and often fatal condition that requires immediate veterinary intervention. The disease’s rapid progression and the nonspecific nature of early signs make early diagnosis and treatment challenging, underscoring the importance of preventive measures, such as vaccination [18,22,23], the main prevention measure, particularly in high-risk regions like the Amazon Biome. Understanding the epidemiological factors and clinical presentation of gas gangrene is crucial for effective management and improving the prognosis for affected horses.
Gas gangrene causes characteristic anatomical and histopathological changes, which can be observed during post-mortem examinations or from biopsy samples [5,6]. In this study and in the literature [2,4,6,7,13] the affected muscles are typically swollen, dark, and friable, with extensive necrosis. There has gas bubbles within the muscle tissue, giving it a “bubble wrap” appearance on palpation. The necrotic tissue exudes a foul-smelling, dark, serosanguineous fluid. The odor is typically pungent due to the anaerobic metabolism of Clostridium bacteria [6]. Gas production by the bacteria leads to subcutaneous emphysema, with palpable crepitus in the overlying skin. This can extend over a significant area of the body, depending on the severity and extent of the infection as observed in the 20 animals. Extensive edema is often present, not only in the affected muscles but also in the surrounding tissues. This edema contributes to circulatory impairment and further tissue damage [15]. The disease progresses quickly, often within hours of infection [14]. The affected area typically presents with severe pain, swelling, and edema. The swelling may rapidly increase in size and is often warm to the touch. The skin over the affected area may change color, becoming pale, reddish, or darkened as the tissue becomes necrotic [24]. As the infection progresses, horses develop a high fever and an elevated heart rate. The horse becomes increasingly lethargic, weak, and reluctant to move due to the severe pain and systemic effects of the toxins [15]. Systemic toxemia leads to multi-organ failure. The disease can progress rapidly to systemic toxemia, sepsis, and death within 24-48 hours if not treated aggressively [6] which was done in the animals in the present study, but because they were not vaccinated, they all died, demonstrating the importance of vaccination in horses against clostridial diseases. In many cases, the progression of gas gangrene is so swift that death occurs before treatment can be effectively administered [18]. The importance of this disease for equine health cannot be overstated, particularly in regions like the Amazon Biome where environmental conditions favor the proliferation of clostridial bacteria, such as C. septicum. The study highlights the critical need for increased awareness, diagnostic capabilities, and preventive measures to mitigate the impact of this devastating disease on equine populations. In equines, the disease’s rapid progression often leaves little time for effective intervention, underscoring the necessity for early detection and treatment, which are currently hampered by a lack of data and awareness among veterinarians and horse owners in the region [6,16,21].
The only detection of C. septicum across all cases indicates that this pathogen may have a unique niche in the Amazon Biome, where environmental factors such as high humidity, warm temperatures, and organic-rich soils create ideal conditions for its survival and proliferation. Unlike other clostridial species, which are often more commonly associated with gas gangrene in temperate climates [6,11,13,14,17], C. septicum appears to dominate in this tropical region. This dominance could be due to the bacterium’s ability to thrive in anaerobic conditions that are more prevalent in the warm, moist environment of the Amazon. Furthermore, the rapid onset of gas gangrene symptoms following trauma or other predisposing factors in these horses highlights the need for immediate intervention upon the first signs of the disease [13,14,15]. Contaminated wounds, particularly deep puncture wounds, surgical sites, or areas of tissue necrosis, are the most common associations with the disease. Gas gangrene in horses is reported worldwide but is particularly prevalent in regions where the bacterium’s spores are common in the soil, such as tropical and subtropical areas [6,7]. The Amazon Biome, with its warm and humid environment, provides ideal conditions for the proliferation of clostridial spores, making horses in this region particularly susceptible.
The incidence of gas gangrene in horses tends to increase during wet seasons, when the soil is more likely to harbor clostridial spores, and horses are more prone to injuries from working in muddy or uneven terrain [3,6,27]. Horses that suffer from penetrating injuries, particularly those involving muscle tissue, are at high risk for gas gangrene. Additionally, surgical procedures, injections with contaminated needles, or even parturition can create favorable conditions for infection. Poor hygiene, inadequate wound care, and inadequate management of surgical sites increase the likelihood of infection [6,7,15]. While the exact incidence of gas gangrene in horses is difficult to determine due to underreporting, it is recognized as a significant cause of morbidity and mortality in horses, particularly in areas with endemic clostridial spores. In this present retrospective study the main predisposing factors observed were the reuse of needles, use of contaminated surgical instruments, sharp tree stumps and barbed wire fences in pastures have also been observed to possibly cause skin lacerations, as have spurs used by riders inflicting puncture wounds . However, the biggest and most important problem observed was lack of vaccination, the main isolated prevention measure against any clostridial disease.
The implications of this study are significant when compared to other Brazilian and global studies on clostridial infections [3,10,11,12,14,15,17,20]. While C. perfringens type A, C. novy type A C. sordelli, C. chauvoei are often reported as primary agents of gas gangrene in livestock worldwide [2,4,7], the predominance of C. septicum in this study suggests a region-specific pathogen profile in the Amazon Biome. This contrasts with findings from other regions where different species of Clostridium are more prevalent. For example, in Brazil [3,10,19,27] and other parts of the world [11,12,15,24,25], C. septicum is not frequently implicated in clostridial myonecrosis. However, the Amazon’s unique ecological conditions appear to select for C. septicum, making it the leading cause of gas gangrene in horses in this area.
The high mortality rate observed in this study highlights the critical need for more effective prevention and control measures [2,4,21,22,23]. Current strategies, including vaccination, have not been fully developed or implemented for C. septicumin equines, particularly in the Amazon Biome. Given the rapid progression of gas gangrene and the high mortality associated with C. septicum infections, there is an urgent need for the development of equine-specific vaccines that target this pathogen [20]. Additionally, the study emphasizes the importance of early diagnosis and prompt treatment. The consistent use of PCR in this study underscores its utility as a diagnostic tool for clostridial infections. However, the reliance on advanced laboratory techniques also points to a gap in diagnostic capabilities in rural and remote areas, where access to such facilities may be limited [21].
In the context of Brazil, and especially within the Amazon Biome, the significance of gas gangrene in equines is magnified by several factors. The Amazon is a vast, remote, and ecologically unique region where veterinary services are often limited, and the infrastructure for disease surveillance and management is underdeveloped. This geographical and infrastructural challenge contributes to the lack of data on the occurrence of gas gangrene in horses, which in turn hinders efforts to understand the true prevalence and impact of the disease. The scarcity of epidemiological data on clostridial infections in the Amazon further complicates the development of targeted prevention and control strategies, leaving equine populations vulnerable to outbreaks with potentially devastating consequences. The study underscores the urgent need for comprehensive epidemiological surveys and the establishment of robust reporting systems to address this gap in knowledge [21,22,23]. Furthermore, horses in the Amazon are frequently exposed to environmental wounds, cuts, and abrasions due to their role in rural activities, which can become easily contaminated with soil and organic matter harboring C. septicum spores. While C. perfringens and C. sordellii [10,12,13,15,17,24] is more commonly reported globally as the primary cause of gas gangrene in horses, our study suggests that in the Amazon, C. septicum plays a predominant role due to these particular environmental factors, however they are necessary more studies to explain this greater occurrence of C. speticum spores to the detriment of other species. This finding in this current study adds to the growing understanding of how geographical and ecological factors can influence pathogen prevalence and disease patterns, making the Amazon Biome a region of special interest for veterinary epidemiology.
Moreover, the lack of diagnosis and awareness among veterinarians and producers about gas gangrene poses a significant barrier to effective disease management in the Amazon Biome. Many veterinarians and equine breeders in the region may be unfamiliar with the clinical signs of gas gangrene, leading to misdiagnosis or delayed diagnosis, which reduces the chances of successful treatment. The disease’s nonspecific early symptoms can be easily overlooked or mistaken for less severe conditions, further complicating timely intervention. This lack of knowledge not only affects animal health and welfare but also has significant economic implications [25,26,27]. The financial impact of gas gangrene on equine breeding in the Amazon is substantial, as the loss of valuable animals to the disease can result in direct financial losses for breeders, as well as broader economic effects on the equine industry in the region.
The findings of this retrospective study highlight the critical need for enhanced veterinary education and training focused on the recognition and management of gas gangrene in equines [28,29]. Additionally, there is an urgent need for the development and dissemination of practical diagnostic tools that can be used in the field by veterinarians and producers in remote areas of the Amazon. The study also calls for increased investment in research to develop effective vaccines [2,4,22,23] and treatment protocols tailored to the specific challenges of managing clostridial infections in equines within the Amazon Biome. By addressing these gaps in knowledge, diagnostics, and disease management, it is possible to reduce the incidence and impact of gas gangrene in equines, ultimately improving the health and productivity of equine populations in the Amazon and beyond.
Polymerase chain reaction (PCR) has emerged as the most widely used diagnostic tool for clostridial myonecrosis [9], primarily due to its high sensitivity, specificity, and rapid turnaround time. Unlike traditional culture methods [26,28], which can be time-consuming and often complicated by the fastidious nature of Clostridium species, PCR allows for the direct detection of clostridial DNA from clinical samples, leading to faster diagnosis and treatment [6]. One of the main advantages of PCR is its ability to detect specific gene sequences that are indicative of pathogenic strains by detecting the genes that encode the presence of clostridial toxin [9]. The ability to identify specific Clostridium species, such as C. perfringens, C. septicum, and others, allows for more targeted treatment strategies, which can be critical in managing the rapid progression of gas gangrene. PCR’s role in the diagnosis of clostridial myonecrosis is further solidified by its application in multiplex assays, which can simultaneously detect multiple pathogens or toxins from a single sample. This multiplexing capability is particularly beneficial in polymicrobial infections or when rapid differentiation between toxin-producing and non-toxin-producing strains is necessary [6,7,9]. Furthermore, the adoption of PCR in veterinary medicine, particularly in regions like the Amazon Biome where clostridial diseases are prevalent, has enhanced the ability of veterinarians to manage outbreaks more effectively. PCR is not only faster but also more accurate than other diagnostic methods, reducing the likelihood of false positives or negatives. Microbiological examination, for example, typically involves the correct collection and immediate shipment of samples. The samples for microbiological analysis can be obtained from affected tissues, fluids from the site of infection, or aspirates from subcutaneous gas pockets [6]. Clostridium species are cultured on specific anaerobic media. However, identification is only confirmed through PCR or MALDI-TOF mass spectrometry, which differentiates between the various Clostridium species. The identification of specific toxins, such as alpha, beta, and other toxins produced by C. perfringens or the lethal toxins of C. septicum, may be performed to confirm the diagnosis and understand the pathogenesis, but it is extremely difficult, as it requires inputs and professionals trained to perform in vivo serumneutralization [2], which is currently discussed from the point of view of the use of laboratory animals for diagnosis.
Gas gangrene in horses, caused primarily by C. septicum, presents with severe clinical pathology, microbiological, and histopathological changes. Understanding these findings is crucial for the accurate diagnosis, treatment, and management of this rapidly progressing and often fatal disease. The comprehensive examination of clinical samples, coupled with detailed anatomical and histopathological analysis, is essential for confirming the diagnosis and understanding the pathogenesis of gas gangrene in horses. Diagnostic improvements: further research should explore the development of rapid and more sensitive diagnostic tools, particularly molecular methods such as real-time PCR, which could allow for earlier and more accurate detection of C. septicum and other clostridial species in equines. Additionally, serological assays could be improved to better identify subclinical or early-stage infections, which may help in preventing the progression of gas gangrene. Vaccine development: given the prevalence of C. septicum in the cases studied and its pathogenicity in horses, the development of a vaccine targeted against this species should be a priority. Research could focus on recombinant vaccine development that targets key virulence factors of C. septicum. Studies assessing the efficacy of multivalent clostridial vaccines in equines, particularly in regions with environmental conditions similar to the Amazon Biome, would be crucial to improving preventive measures. Gas gangrene, primarily caused by histotoxic Clostridium species such as C. septicum, is a severe and often fatal condition in horses [2,4,20,21]. Preventing gas gangrene is critical for maintaining the health and productivity of horses, especially in regions where these infections are prevalent. Various preventive measures can be employed: a). Prompt and thorough cleaning of wounds is essential to prevent the introduction and proliferation of Clostridium spores, which thrive in anaerobic conditions; b). Applying antiseptics to wounds and administering prophylactic antibiotics can help reduce the risk of infection, especially in deep or puncture wounds; c). Maintaining clean and dry stables reduces the risk of environmental contamination with Clostridium spores. Proper disposal of manure and organic waste is also crucial to minimize exposure; d). Ensuring that feed and bedding materials are free from contamination with Clostridium spores can prevent infections originating from the environment; e). Where available, regular vaccination schedules should be adhered to, especially in regions prone to clostridial infections; f). Regular veterinary examinations can help detect early signs of infection, allowing for prompt treatment before the disease progresses.
While vaccines for clostridial diseases are available for other livestock, such as cattle and sheep, there is a notable gap in the availability of equine-specific vaccines for gas gangrene [2,4,22,23,24]. The development of such vaccines is crucial for several reasons: 1). Species-specific immunogenicity: horses may respond differently to vaccines designed for other species, necessitating the development of vaccines tailored to their immune systems for optimal protection. 2). Disease prevalence: in regions where gas gangrene is common among equines, an equine-specific vaccine could significantly reduce the incidence and severity of the disease, thereby reducing mortality rates and improving animal welfare. 3). Economic impact: gas gangrene can cause significant economic losses in equine industries, particularly in areas where horses are used for labor, transportation, or competitive sports. Vaccines could mitigate these losses by preventing outbreaks and reducing the need for costly treatments.
The development of new vaccines and vaccine methodologies [2,4,21,22] is critical to advancing equine husbandry and preventing clostridial diseases like gas gangrene. Key areas of focus include: 1). Next-Generation Vaccines: a) Subunit vaccines: these vaccines use specific antigens, such as toxins or surface proteins, to elicit an immune response without using whole bacteria. They offer a safer alternative with fewer side effects; b).Toxoid vaccines: which use inactivated toxins, could be particularly effective against gas gangrene, as the disease’s pathology is largely driven by toxin production. 2). Adjuvants and delivery systems: a). Innovative adjuvants: the use of advanced adjuvants can enhance the immune response, allowing for lower doses of the antigen and potentially reducing the frequency of booster shots; b). Novel delivery systems: research into delivery systems such as nanoparticles or liposomes could improve the stability and efficacy of vaccines, making them more effective in challenging environmental conditions. 3). DNA and mRNA vaccines: these vaccines involve the introduction of plasmid DNA encoding the antigen into the host, prompting the production of the antigen and an immune response. DNA vaccines are stable, easy to produce, and offer the potential for rapid development. mRNA vaccines the success of mRNA vaccines in human medicine, particularly for COVID-19, suggests that similar technologies could be adapted for use in equines. These vaccines can be rapidly designed and produced, offering a flexible platform for responding to emerging clostridial strains. 4). Field-applicable vaccines thermostable formulations: developing vaccines that do not require refrigeration would be particularly beneficial in remote or resource-limited areas, where cold chain logistics are challenging. 5). Single-dose vaccines: single-dose formulations would simplify vaccination protocols, making them more practical for use by farmers and veterinarians in the field. Preventing gas gangrene in equines requires a multifaceted approach, combining proper wound care, environmental management, and vaccination. The development of equine-specific vaccines is a critical step in enhancing disease prevention strategies. Continued research and innovation in vaccine technologies are essential for creating more effective, accessible, and field-ready vaccines. These advancements will not only improve equine health and productivity but also contribute to the sustainability of equine industries world wide [2,4,21,23].
In conclusion, the findings from this study provide valuable epidemiological data on gas gangrene in horses in the Amazon Biome and highlight the need for region-specific interventions. The predominance of C. septicum in these cases suggests that this pathogen is a major threat to equine health in this region, necessitating targeted research, improved diagnostic tools, and the development of vaccines tailored to the unique challenges of the Amazon environment. The study also calls for increased awareness among veterinarians and horse owners about the risks of C. septicum and the importance of rapid response to prevent the high mortality associated with gas gangrene. In the Amazon Biome, the hot, humid, and tropical climate creates an ideal environment for the proliferation of Clostridium species, which are responsible for gas gangrene. These conditions favor the survival of the bacteria in the soil, water, and organic material, leading to a higher risk of infection in horses that may have wounds or injuries, particularly in humid pastures or wetlands. The constant exposure to these environmental factors increases the likelihood of contamination and may exacerbate the progression of the disease. The management of gas gangrene in this context requires careful attention to the early detection of wounds, proper wound care, and effective sanitation practices. The challenges of maintaining hygiene in the Amazon’s rural areas, where access to veterinary care may be limited, can delay treatment and result in more severe cases. Additionally, the rapid onset and progression of gas gangrene, often exacerbated by the local climate, underscore the importance of timely interventions such as aggressive surgical debridement and the administration of broad-spectrum antibiotics. Considering the endemicity of clostridial bacteria in this region, preventive measures, including vaccination programs and controlled grazing practices, become critical for reducing the incidence of gas gangrene in horses. Overall, the environmental conditions of the Amazon Biome significantly impact the development, progression, and management of gas gangrene, necessitating tailored approaches to veterinary care in this unique setting.

5. Conclusions

This is the first work in the world in which the consistent identification of C. septicum across all cases emphasizes the need for improved targeted preventive measures, including wound management and hygiene practices in equine care. Furthermore, this research calls for increased awareness among veterinarians and horse owners in the Amazon region regarding the risks of gas gangrene, particularly following traumatic injuries or surgical procedures. The study’s conclusions contribute valuable knowledge to the understanding of gas gangrene in horses, advocating for enhanced prevention (vaccination), rapid diagnosis, and effective treatment strategies to mitigate the devastating effects of this disease in the Amazon Biome.

Author Contributions

Conceptualization, F.M.S.; methodology, L.A.d.S., I.C.F.B., H.G.d.S.O., L.O.d.S., M.A.O.M., A.d.M.C.L., J.B.d.S., F.M.S.M. and F.M.S.; formal analysis, L.A.d.S., I.C.F.B., H.G.d.S.O., L.O.d.S., M.A.O.M., A.d.M.C.L., J.B.d.S., F.M.S.M. and F.M.S.; investigation, L.A.d.S., I.C.F.B., H.G.d.S.O., L.O.d.S., M.A.O.M., A.d.M.C.L., J.B.d.S., F.M.S.M. and F.M.S.; data curation, L.A.d.S., I.C.F.B., H.G.d.S.O., A.d.M.C.L., J.B.d.S., F.M.S.M. and F.M.S; writing—original draft preparation, L.A.d.S., I.C.F.B., H.G.d.S.O., A.d.M.C.L., J.B.d.S., F.M.S.M. and F.M.S.; writing—review and editing, F.M.S.; supervision, F.M.S.; project administration, F.M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The animal study protocol number CEUA 6261300323 (ID 002208) was approved by the National Council for Control of Animal Experimentation (CONCEA), and was approved by the Ethical Committee on Animal Use of the Federal University of Para (CEUA/UFPA).

Informed Consent Statement

All the animals in the current study belong to farm owners in the state of Pará, Brazilian Amazon Biome, and all signed the consent terms.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), FAPESPA (Fundação Amazônia de Amparo a Estudos e Pesquisas do Estado do Pará), CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Finance Code 001); PROPESP-UFPA (Pró-Reitoria de Pesquisa e Pós-Graduação da Universidade Federal do Pará) for funding the publication of this article via the Qualified Publication Support Program – PAPQ/2024; Anaerobic Laboratory of the Federal University of Minas Gerais; Biological Institut of São Paulo and UFPA animal pathology laboratory.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. MAPA - Ministério da Agricultura, pecuária e abastecimento - Brasil – 2021. Accessed: https://www.gov.br/agricultura/pt-br/assuntos/politica-agricola/todas-publicacoes-de-politica-agricola/agropecuaria-brasileira-em-numeros/abn-02-2021.pdf.
  2. Freitas, N.F.Q.R.; Otaka, D.Y.; Galvão, C.C.; de Almeida, D.M.; Ferreira, M.R.; Júnior, C.M.; Hidalgo, M.M.M.H.; Conceição, F.R.; Salvarani, F.M. Humoral immune response evaluation in horses vaccinated with recombinant Clostridium perfringens toxoids alpha and beta for 12 months. Toxins 2021, 13, 566. [Google Scholar] [CrossRef] [PubMed]
  3. Farias, L.D.; Azevedo, M.D.S.; Trost, M.E.; De La Côrte, F.D.; Irigoyen, L.F.; de Vargas, A.C. Acute Myonecrosis in Horse Caused by Clostridium novyi Type A. Braz. J. Microbiol. 2014, 45, 221–224. [Google Scholar] [CrossRef] [PubMed]
  4. Freitas, N.F.Q.R.; Barbosa, J.D.; Otaka, D.Y.; Ferreira, M.R.A.; Rodrigues, R.R.; Junior, C.M.; Conceição, F.R.; Salvarani, F.M. Clostridium perfringens α and β recombinant toxoids in equine immunization. Pesq. Vet. Bras. 2020, 40, 776–780. [Google Scholar] [CrossRef]
  5. Amorim, R.M.; Rino, A.S.; Dal-Pai-Silva, M.; Borges, A.S.; Oliveira Filho, J.P.; Freitas, N.P.P.; Maia, L.; Rezende, L.A.L. Aspectos morfológicos de biópsias musculares em equinos com miopatia sob forma de surto. Pesq. Vet. Bras 2011, 31, 479–585. [Google Scholar] [CrossRef]
  6. Uzal, F.A.; Navarro, M.A.; Asin, J.; Henderson, E.E. Clostridial Diseases of Horses: A Review. Vaccines 2022, 10, 318. [Google Scholar] [CrossRef]
  7. Junior, C.A.O.; Silva, R.O.; Lobato, F.C.; Navarro, M.A.; Uzal, F.A. Gas gangrene in mammals: a review. J. Vet. Diag. Invest. 2020, 32, 175–183. [Google Scholar] [CrossRef]
  8. Feitosa, F.L.F. Semiologia: a arte do diagnóstico. 4ed. Editora Roca, São Paulo, SP, Brazil, 2020; pp-55-58.
  9. Ribeiro, M.G.; Silva, R.O.S.; Pires, P.S.; Martinho, A.P.V.; Lucas, T.M.; Teixeira, A.I.P.; Paes, A.C.; Barros, C.B.; Lobato, F.C.F. Myonecrosis by Clostridium septicum in a dog, diagnosed by a new multiplex-PCR. Anaerobe 2012, 8, 504–507. [Google Scholar] [CrossRef]
  10. Ferreira Junior, J.A.; Silveira, R.O.S.; Lobato, F.C.F.; Teixeira Neto, A.R.; Nascimento, K.A.; Almeida e Macedo, J.T.S.; Pedroso, P.M.O. Malignant Edema in Horse by Clostridium perfringens Type A. Acta Scien. Vet., 2020, 48. [Google Scholar] [CrossRef]
  11. Stevens, D.L.; Musher, D.M.; Watson, D.A.; Eddy, H.; Hamill, R.J.; Gyorkey, F.; Rosen, H.; Mader, J. Spontaneous, nontraumatic gas gangrene due to Clostridium septicum. Rev. Inf. Dis. 1990, 12, 286–296. [Google Scholar] [CrossRef]
  12. Sacco, S.C.; Ortega, J.; Navarro, M.A.; Fresneda, K.C.; Anderson, M.; Woods, L.W.; Moore, J.; Uzal, F.A. Clostridium sordellii associated gas gangrene in 8 horses, 1998-2019. J. Vet. Diag. Invest. 2020, 32, 246–251. [Google Scholar] [CrossRef]
  13. Elkbuli, A.; Diaz, B.; Ehrhardt, J.D.; Hai, S.; Kaufman, S.; McKenney, M.; Boneva, D. Survival from Clostridium toxic shock syndrome: Case report and review of the literature. Int. J. Surg. Case. Rep. 2018, 50, 64–67. [Google Scholar] [CrossRef] [PubMed]
  14. Breauhaus, B.A.; Brown, C.M.; Scott, E.A.; Ainsworth, D.M.; Taylor, R.F. Clostridial muscle infections following intramuscular injections in the horse. J. Equine Vet Sci. 1983, 3, 42–46. [Google Scholar] [CrossRef]
  15. Peek, S.F.; Semrad, S.D.; Perkins, G.A. Clostridial myonecrosis in horses (37 cases 1985-2000). Equine Vet. J. 2003, 35, 86–92. [Google Scholar] [CrossRef] [PubMed]
  16. Vengust, M.; Arroyo, L.G.; Weese, J.S.; Baird, J.D. Preliminary evidence for dormant clostridial spores in equine skeletal muscle. Equine Vet. J. 2003, 35, 514–516. [Google Scholar] [CrossRef]
  17. Ray, D.; Cohle, S.D.; Lamb, P. Spontaneous clostridial myonecrosis. J. For. Sci. 1992, 37, 1428–1432. [Google Scholar] [CrossRef]
  18. Songer, J.G. Clostridial diseases of animals. In The Clostridia: Molecular Biology and Pathogenesis, 1st ed.; Academic Press: San Diego, EUA, 1997; pp. 153–180. [Google Scholar] [CrossRef]
  19. Seeger, M.G.; Silva, G.B.; Machado, C.S.; Silva, D.R.P.D.; Corte, F.D.D.L.; Vogel, F.S.F.; Cargnelutti, J.F. Myonecrosis caused by Clostridium septicum in a horse from Southern Brazil. Ciên. Rur. 2022, 52, e20210736. [Google Scholar] [CrossRef]
  20. Kennedy, C.L.; Lyras, D.; Cheung, J.K.; Hiscox, T.J.; Emmins, J.J.; Rood, J.I. Cross-complementation of Clostridium perfringens PLC and Clostridium septicum a-toxin mutants reveals PLC is sufficient to mediate gas gangrene. Mic. Infec. 2009, 11, 413–418. [Google Scholar] [CrossRef]
  21. Ferreira, M.R.; Moreira, G.M.; Cunha, C.E.; Mendonça, M.; Salvarani, F.M.; Moreira, A.N.; Conceição, F.R. Recombinant alpha, beta, and epsilon toxins of Clostridium perfringens: production strategies and applications as veterinary vaccines. Toxins 2019, 8, 340. [Google Scholar] [CrossRef]
  22. Zaragoza, N.E.; Orellana, C.A.; Moonen, G.A.; Moutafis, G.; Marcellin, E. Vaccine Production to protect animals against pathogenic Clostridia. Toxins 2019, 11, 525. [Google Scholar] [CrossRef]
  23. Alves, M.L.F.; Ferreira, M.R.A.; Donassolo, R.A.; Rodrigues, R.R.; Conceição, F.R. Clostridium septicum: A review in the light of alpha-toxin and development of vaccines. Vaccine 2021, 39, 4949–4956. [Google Scholar] [CrossRef]
  24. Choi, Y.K.; Kang, M.S.; Yoo, H.S.; Lee, D.Y.; Lee, H.C.; Kim, D.Y. Clostridium perfringens Type A Myonecrosis in a Horse in Korea. J. Vet. Med. Sci. 2003, 65, 1245–1247. [Google Scholar] [CrossRef] [PubMed]
  25. Lemfers, T.R.; Von Ah, R.M.L.; Gagliardi, B.; Pucci, L.R.; Stanciar, B.P.; Dércoli, T.E.; Calefi, A.S. Systemic Clostridiosis due to Clostridium perfringens infection in Equus Asinus – Case Report. Ars Vet. 2022, 38, 180–184. [Google Scholar] [CrossRef]
  26. Hustá, M.; Ducatelle, R.; Haesebrouck, F.; Van Immerseel, F.; Goossens, E. A comparative study on the use of selective media for the enumeration of Clostridium perfringens in poultry faeces. Anaerobe 2020, 63, 102205. [Google Scholar] [CrossRef] [PubMed]
  27. Raymundo, D.L.; Pavarini, S.P.; Bezerra Junior, P.S.; Antoniassi, N.A.B.; Bandarra, P.M.; Bercht, B.S.; Gomes, M.J.P.; Driemeier, D. Mionecrose aguda por Clostridium septicum em equinos. Pesq. Vet. Bras. 2010, 30, 637–640. [Google Scholar] [CrossRef]
  28. Morris, W.E.; Uzal, F.A.; Fattorini, F.R.; Terzolo, H. Malignant oedema associated with blood-sampling in sheep. Aust. Vet. J. 2002, 5, 280–281. [Google Scholar] [CrossRef]
Figure 1. Equine nº 5 with gas gangrene: (a) increased volume of the left hind limb; (b) hemorrhage and subcutaneous edema, with extravasation of serosanguineous fluid, liquefaction, and tissue necrosis (postmortem).
Figure 1. Equine nº 5 with gas gangrene: (a) increased volume of the left hind limb; (b) hemorrhage and subcutaneous edema, with extravasation of serosanguineous fluid, liquefaction, and tissue necrosis (postmortem).
Preprints 140732 g001

Horses Sex1 Age City PCR Treatment2 Vaccination Outcome
1 F 2 years Castanhal Clostridium septicum T2 No Death
2 M 10 months Castanhal Clostridium septicum T1 No Death
3 M 7 years Castanhal Clostridium septicum T1 No Death
4 M 4 years Castanhal Clostridium septicum T1 No Death
5 M 3 years Castanhal Clostridium septicum T2 No Death
6 M 5 years Novo Progresso Clostridium septicum T1 No Death
7 M 6 years Novo Progresso Clostridium septicum T1 No Death
8 M 8 years Novo Progresso Clostridium septicum T1 No Death
9 F 2 years Santo Antônio do Tauá Clostridium septicum T2 No Death
10 M 9 years Santo Antônio do Tauá Clostridium septicum T1 No Death
11 F 9 years Santo Antônio do Tauá Clostridium septicum T1 No Death
12 M 9 months Santo Antônio do Tauá Clostridium septicum T2 No Death
13 M 3 years Santo Antônio do Tauá Clostridium septicum T1 No Death
14 F 11years São Félix do Xingú Clostridium septicum T1 No Death
15 M 10 years São Félix do Xingú Clostridium septicum T1 No Death
16 M 8 years São Félix do Xingú Clostridium septicum T1 No Death
17 M 9 years São Félix do Xingú Clostridium septicum T2 No Death
18 M 12 years São Félix do Xingú Clostridium septicum T2 No Death
19 M 2,5 years Soure (Marajo Island) Clostridium septicum T2 No Death
20 M 2 years Soure (Marajo Island) Clostridium septicum T2 No Death
1 M = male; F = female; T1 = treatment 1 (Penicilin G + dexamethasone); T2 = treatment 2 (Penicilin G+ Flunixim meglumine);.
Figure 2. Equine nº5 with gas gangrene: (a) hemorrhage and subcutaneous edema, with extravasation of serosanguineous fluid, liquefaction, and tissue necrosis in the pectoral region; (b) ventral subcutaneous edema (postmortem).
Figure 2. Equine nº5 with gas gangrene: (a) hemorrhage and subcutaneous edema, with extravasation of serosanguineous fluid, liquefaction, and tissue necrosis in the pectoral region; (b) ventral subcutaneous edema (postmortem).
Preprints 140732 g002
Figure 3. Equine gas gangrene: (a) Degeneration and hyaline necrosis of muscle fibers with intense inflammatory infiltrate [H&E obj. 10×]; (b) area of necrosis associated with edema with hemorrhage [H&E obj. 20×].
Figure 3. Equine gas gangrene: (a) Degeneration and hyaline necrosis of muscle fibers with intense inflammatory infiltrate [H&E obj. 10×]; (b) area of necrosis associated with edema with hemorrhage [H&E obj. 20×].
Preprints 140732 g003
Table 1. Identification of animals, sex, age, city, PCR result, treatment, vaccination against clostridial diseases and cases outcome of 20 horses suspected of gas gangrene in the state of Pará, Amazon Biome, Brazil.
Table 1. Identification of animals, sex, age, city, PCR result, treatment, vaccination against clostridial diseases and cases outcome of 20 horses suspected of gas gangrene in the state of Pará, Amazon Biome, Brazil.
Horses Sex1 Age City PCR Treatment2 Vaccination Outcome
1 F 2 years Castanhal Clostridium septicum T2 No Death
2 M 10 months Castanhal Clostridium septicum T1 No Death
3 M 7 years Castanhal Clostridium septicum T1 No Death
4 M 4 years Castanhal Clostridium septicum T1 No Death
5 M 3 years Castanhal Clostridium septicum T2 No Death
6 M 5 years Novo Progresso Clostridium septicum T1 No Death
7 M 6 years Novo Progresso Clostridium septicum T1 No Death
8 M 8 years Novo Progresso Clostridium septicum T1 No Death
9 F 2 years Santo Antônio do Tauá Clostridium septicum T2 No Death
10 M 9 years Santo Antônio do Tauá Clostridium septicum T1 No Death
11 F 9 years Santo Antônio do Tauá Clostridium septicum T1 No Death
12 M 9 months Santo Antônio do Tauá Clostridium septicum T2 No Death
13 M 3 years Santo Antônio do Tauá Clostridium septicum T1 No Death
14 F 11years São Félix do Xingú Clostridium septicum T1 No Death
15 M 10 years São Félix do Xingú Clostridium septicum T1 No Death
16 M 8 years São Félix do Xingú Clostridium septicum T1 No Death
17 M 9 years São Félix do Xingú Clostridium septicum T2 No Death
18 M 12 years São Félix do Xingú Clostridium septicum T2 No Death
19 M 2,5 years Soure (Marajo Island) Clostridium septicum T2 No Death
20 M 2 years Soure (Marajo Island) Clostridium septicum T2 No Death
1 M = male; F = female; T1 = treatment 1 (Penicilin G + dexamethasone); T2 = treatment 2 (Penicilin G+ Flunixim meglumine);.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated